Rimantadine and arbidol sensitivity of influenza viruses that caused epidemic morbidity rise in Russia in the 2004-2005 season

Voprosy Virusologii

Volumn 52, Issue 2, 2007, Pages 24-29

  Burtseva, Ye I ^a   Shevchenko, Ye S ^a   Leneva, I A ^a   Merkulova, L N ^a   Oskerko, T A ^a   Shlyapnikova, O V ^a   Zaplatnikov, A L ^a   Shuster, A M ^a   Slepushkin, A N ^a  

^a NONE

Author keywords

Arbidol; In vitro resistance; Influenza viruses; Rimantadine

Indexed keywords

CERCOPITHECINE HERPESVIRUS 1; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZAVIRUS A; INFLUENZAVIRUS B; ORTHOMYXOVIRIDAE;

EID: 34248140233     PISSN: 05074088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Russian source
6. Russian source
7. Russian source
8. Russian source
9. Bright R. A., Medina M., Xu X. et al. Incidence of adamantane resistance among influenza A(H3N2) viruses isolated worldwide from 1994 to 2005: a cause to concern // Published Online. - 2005. - September 22.
10. CDC/WHO Avian Influenza Response Team. Outbreaks of avian influenza A(H5N1) in Asia and interim recommendations for evaluation and reporting of suspected cases - United States // Morbid. Mortal. Wkly Rep. - 2004. - Vol. 53. - P. 97-100.
11. Davies H. W., Appleyard G., Cunninghan P., Pereira M. S. The use of continuous cell line for the isolation of influenza virus // Bull. Wld Hlth Org. - 1978. - Vol. 56. - P. 1991-1993.
12. Hayden F. G., Belshe R. B., Clover R. D. et al. Emergence and apparent transmission of Rimantadine-resistant influenza A virus in families // N. Engl. J. Med. - 1989. - Vol. 321. - P. 1696-1702.
13. Hayden F. G. Perspectives on antiviral use during pandemic influenza // Philos. Trans. Roy. Soc. Lond. B. - 2001. - Vol. 359. - P. 1877-1884.
14. High levels of adamantine resistance among influenza A(H3N2) viruses and interim guidelines for use of antiviral agents in United States, 2005-2006 influenza season // www.cdc.gov/mmwr. - 2006. - Vol. 55 (02). - P. 44-46.
15. Kiso M., Mitamura K., Sakai-Tagawa Y. et al. Resistant influenza A viruses in children treated with oseltamivir descriptive study // Lancet. - 2004. - Vol. 364. - P. 759-765.
16. Leneva I., Hay A. The mechanism of action of arbidol against influenza virus-selection and characterization of arbidol-resistant mutants // 12-th International Congress of Virology. - Paris, 2002. - Abstr. 1077.
17. Monto A., Arden N. Implications of viral resistance to amantadine in control of influenza A // Clin. Infect. Dis. - 1992. Vol. 15. - P. 362-367.
18. Monto A. S. Vaccines and antiviral drugs in pandemic prepardness // Emerg. Infect. Dis. - 2006. - Vol. 12, N 1. - P. 55-60.
19. Ziegler T., Hemphill M., Ziegler M. et al. Low incidence of rimantadine resistance in field isolates of influenza A viruses // J. Infect. Dis. - 1999. - Vol. 180. - P. 935-939.